Receptor tyrosine - Globe Thesis

Keyword [Receptor tyrosine] Result: 141 - 160 \| Page: 8 of 10
141.	Mechanism Of Mast Cells Involved In Chronic Pancreatitis Pain
142.	Treatment And Prognosis Analysis Of 60 Cases Of Different EGFR Mutations Status In Non-small Cell Lung Cancer With Brain Metastasis
143.	Filamin A Is Correlated With Sensitivity To Third Generation EGFR-TKIs In Lung Adenocarcinoma H1975 Cell With EGFR T790M Mutation
144.	Intercalated Combination Of Chemotherapy And EGFR-TKIs Versus Chemotherapy Alone In The First-line Treatment Of Advanced Non-small Cell Lung Cancer: A Meta-analysis
145.	Correlation Of EGFR Mutation With Brain Metastases In Non-small Cell Lung Cancer
146.	Investigation Of EGFR Gene Mutation In Lung Squamous Cell Carcinoma And The Effect Of EGFR-TKI Treatment On Advanced EGFR Mutation
147.	The Clinical Observation Of EGFR-TKI Rechallenge With Antiangiogenic Agents In Advanced NSCLC
148.	Molecular Mechanism Of EPSH In Receptor Tyrosine Kinase Trafficking
149.	The Differences Of Efficacy Of Chemotherapy And Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor In Advanced Lung Adenocarcinoma Patients Harboring 19del And L858R Mutation
150.	The Role Of DDR2 In Pulmonary Fibrosis And Its Role In TGF-? Signaling Pathway
151.	Comparison Of The Clinical Outcome Of Gefitinib For Advanced Lung Adenocarcinoma With Positive Epidermal Growth Factor Receptor Mutated In Exon 21 Or 19 Del Between Patients Treated With First And Second Line Therapy
152.	Treatment Strategies To Acquired Resistance Of EGFR-TKIs In Non-small-cell Lung Cancer Patients
153.	Non-small Cell Lung Cancer NCI-H460 Cell Driven Receptor Tyrosine Kinase High-Expression Molecular Regulation Mechansim Research
154.	Role Of EMT In Radiosensitivity Of NSCLC With Acquired Resistance Of EGFR-TKI
155.	Efficacy And Safety Of Stereotactic Body Radiation Therapy In The Management Of Oligopersistent Disease In Patients With Egfr Mutant Non-small Cell Lung Cancer During EGFR-TKIs Treatment
156.	The Clinical Study And The Mechanism On The Reversion Of Acquired Resistance With The First Generation EGRF-TKIs For Advanced NSCLC Patients
157.	Discovery Of Novel Type ? Kinase Inhibitors For Class ? Tyrosine Kinases
158.	Clinical Studies And Prognostic Analysis Of Leptomeningeal Metastases From Lung Cancer And Adenosquamous Lung Carcinoma
159.	Establishment Of Third Generation EGFR-TKI Osimertinib Acquired Resistant NSCLC Cell Line And Preliminary Study On Resistance Mechanism
160.	Clinical And Experimental Study On The Relationship Between Hyperglycemia And Gastrointestinal Stromal Tumor
<<First <Prev Next> Last>> Jump to